Cyclosporine therapy during the COVID-19 pandemic

J Am Acad Dermatol. 2020 Aug;83(2):e151-e152. doi: 10.1016/j.jaad.2020.04.153. Epub 2020 May 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoimmune Diseases / drug therapy*
  • Betacoronavirus / drug effects
  • Betacoronavirus / immunology*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Cyclosporins / pharmacology*
  • Cyclosporins / therapeutic use
  • Humans
  • Middle East Respiratory Syndrome Coronavirus / drug effects
  • Middle East Respiratory Syndrome Coronavirus / immunology
  • Pandemics / prevention & control*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology
  • SARS Virus / drug effects
  • SARS Virus / immunology
  • Severe Acute Respiratory Syndrome / epidemiology
  • Severe Acute Respiratory Syndrome / immunology
  • Severe Acute Respiratory Syndrome / prevention & control
  • Severe Acute Respiratory Syndrome / virology
  • Virus Replication / drug effects*

Substances

  • Cyclosporins

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2